Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2020-2026

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Celecoxib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
1.5.2 Drug Store
1.5.3 Hospital Pharmacies
1.5.4 Online
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
2.3.6 Primary Interviews with Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.4 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.5 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)
5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application (2015-2026)
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
8 China
8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
8.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
9.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
9.4 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
11 India
11.1 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
11.3 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
11.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
12.4 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Roche (Genentech)
13.1.1 Roche (Genentech) Company Details
13.1.2 Roche (Genentech) Business Overview and Its Total Revenue
13.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
13.1.5 Roche (Genentech) Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview and Its Total Revenue
13.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 B-MS
13.3.1 B-MS Company Details
13.3.2 B-MS Business Overview and Its Total Revenue
13.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.3.5 B-MS Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview and Its Total Revenue
13.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Eli Lilly and Company
13.7.1 Eli Lilly and Company Company Details
13.7.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.7.5 Eli Lilly and Company Recent Development
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Details
13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
13.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.8.5 Johnson & Johnson Recent Development
13.9 GSK
13.9.1 GSK Company Details
13.9.2 GSK Business Overview and Its Total Revenue
13.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.9.5 GSK Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview and Its Total Revenue
13.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
13.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Details
10.11.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.11.5 Boehringer Ingelheim Recent Development
13.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview and Its Total Revenue
10.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Market Segments
Table 2. Key Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
Table 3. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aspirin
Table 6. Key Players of Ibuprofen
Table 7. Key Players of Naproxen
Table 8. Key Players of Celecoxib
Table 9. Key Players of Others
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2015-2020)
Table 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
Table 20. Main Points Interviewed from Key Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players
Table 21. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2015-2020)
Table 23. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019)
Table 24. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 27. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Type (2015-2020)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2021-2026)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2015-2020)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 41. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 47. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 49. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 50. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 51. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 52. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 53. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 55. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 57. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 61. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 63. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 65. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 67. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 68. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 69. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 70. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share (2019-2020)
Table 73. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2015-2020)
Table 75. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2015-2020)
Table 77. Roche (Genentech) Company Details
Table 78. Roche (Genentech) Business Overview
Table 79. Roche (Genentech) Product
Table 80. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 81. Roche (Genentech) Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. B-MS Company Details
Table 88. B-MS Business Overview
Table 89. B-MS Product
Table 90. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 91. B-MS Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Product
Table 95. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 96. Merck Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Product
Table 100. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 101. Pfizer Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Product
Table 105. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 106. Novartis Recent Development
Table 107. Eli Lilly and Company Company Details
Table 108. Eli Lilly and Company Business Overview
Table 109. Eli Lilly and Company Product
Table 110. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 111. Eli Lilly and Company Recent Development
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Product
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 116. Johnson & Johnson Recent Development
Table 117. GSK Company Details
Table 118. GSK Business Overview
Table 119. GSK Product
Table 120. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 121. GSK Recent Development
Table 122. Sanofi Company Details
Table 123. Sanofi Business Overview
Table 124. Sanofi Product
Table 125. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 126. Sanofi Recent Development
Table 127. Boehringer Ingelheim Company Details
Table 128. Boehringer Ingelheim Business Overview
Table 129. Boehringer Ingelheim Product
Table 130. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 131. Boehringer Ingelheim Recent Development
Table 132. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 133. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 134. Zhejiang Jiuzhou Pharmaceutical Product
Table 135. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020) (Million US$)
Table 136. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2026
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2026
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2019
Figure 17. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
Figure 19. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Roche (Genentech) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 30. B-MS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 36. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 38. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 42. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 44. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 46. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 48. Zhejiang Jiuzhou Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs